• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在双膦酸盐治疗患者中使用基于富血小板纤维蛋白(PRF)的自体膜进行拔牙:一例报告

Use of Platelet Rich Fibrin (PRF)-Based Autologous Membranes for Tooth Extraction in Patients under Bisphosphonate Therapy: A Case Report.

作者信息

Pispero Alberto, Bancora Ivan, Khalil Antonious, Scarnò Dario, Varoni Elena M

机构信息

Dipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, University of Milan, Via Beldiletto 1, 20142 Milano, Italy.

出版信息

Biomedicines. 2019 Nov 10;7(4):89. doi: 10.3390/biomedicines7040089.

DOI:10.3390/biomedicines7040089
PMID:31717656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6966576/
Abstract

Tooth extraction in patients treated with bisphosphonates (BPs) for osteoporosis or cancer exposes the patient to the risk of osteonecrosis of the jaw. An autologous membrane using platelet-rich fibrin (PRF) is an innovative technique to promote wound healing, which allows obtaining a hermetic closure of the post-extractive surgical site without the need of mucoperiosteal flaps or periosteal releasing incisions. Here, we report the case of a 70-year-old woman, in therapy with alendronate for 12 years, requiring the upper right premolar extraction because of a crown fracture. After the tooth extraction performed under antiseptic and antibiotic coverage, the PRF autologous membrane was placed on the surgical wound to close completely the post-extraction site. Follow-up visits were carried out after one, two, four weeks and two months from the intervention. The complete re-epithelization of the wound was observed without signs of infection. The use of PRF for the closure of post-extraction sockets in patients taking BPs appears to be a promising alternative to the more invasive surgical procedures. Future clinical trials will be pivotal in elucidating the effectiveness of PRF to prevent BP-related osteonecrosis after tooth extraction.

摘要

对于因骨质疏松症或癌症而接受双膦酸盐(BP)治疗的患者,拔牙会使其面临颌骨坏死的风险。使用富血小板纤维蛋白(PRF)的自体膜是一种促进伤口愈合的创新技术,它能够在无需黏膜骨膜瓣或骨膜松解切口的情况下,实现拔牙后手术部位的密闭缝合。在此,我们报告一例70岁女性病例,该患者接受阿仑膦酸钠治疗12年,因冠折需要拔除右上颌前磨牙。在抗菌和抗生素覆盖下进行拔牙后,将PRF自体膜放置在手术伤口上,以完全封闭拔牙部位。在干预后的1周、2周、4周和2个月进行随访。观察到伤口完全重新上皮化,无感染迹象。在服用BP的患者中,使用PRF封闭拔牙窝似乎是一种比更具侵入性的手术方法更有前景的替代方案。未来的临床试验对于阐明PRF预防拔牙后BP相关骨坏死的有效性至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/598e/6966576/38883a66b17d/biomedicines-07-00089-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/598e/6966576/2c47de92a928/biomedicines-07-00089-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/598e/6966576/b80993fc6145/biomedicines-07-00089-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/598e/6966576/b5ee657fadeb/biomedicines-07-00089-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/598e/6966576/824cdbc9f766/biomedicines-07-00089-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/598e/6966576/005e4d034760/biomedicines-07-00089-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/598e/6966576/089c3decd9c8/biomedicines-07-00089-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/598e/6966576/5684f8d07217/biomedicines-07-00089-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/598e/6966576/043d6d5912cd/biomedicines-07-00089-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/598e/6966576/38883a66b17d/biomedicines-07-00089-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/598e/6966576/2c47de92a928/biomedicines-07-00089-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/598e/6966576/b80993fc6145/biomedicines-07-00089-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/598e/6966576/b5ee657fadeb/biomedicines-07-00089-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/598e/6966576/824cdbc9f766/biomedicines-07-00089-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/598e/6966576/005e4d034760/biomedicines-07-00089-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/598e/6966576/089c3decd9c8/biomedicines-07-00089-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/598e/6966576/5684f8d07217/biomedicines-07-00089-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/598e/6966576/043d6d5912cd/biomedicines-07-00089-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/598e/6966576/38883a66b17d/biomedicines-07-00089-g009.jpg

相似文献

1
Use of Platelet Rich Fibrin (PRF)-Based Autologous Membranes for Tooth Extraction in Patients under Bisphosphonate Therapy: A Case Report.在双膦酸盐治疗患者中使用基于富血小板纤维蛋白(PRF)的自体膜进行拔牙:一例报告
Biomedicines. 2019 Nov 10;7(4):89. doi: 10.3390/biomedicines7040089.
2
Tooth extractions in patients under antiresorptive therapy for osteoporosis: Primary closure of the extraction socket with a mucoperiosteal flap versus application of platelet-rich fibrin for the prevention of antiresorptive agent-related osteonecrosis of the jaw.骨质疏松症抗吸收治疗患者的拔牙:拔牙窝采用黏膜骨瓣行一期关闭与富血小板纤维蛋白应用预防抗吸收药物相关的颌骨坏死。
J Craniomaxillofac Surg. 2020 Apr;48(4):444-451. doi: 10.1016/j.jcms.2020.02.006. Epub 2020 Feb 18.
3
Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: a trial study.富血小板纤维蛋白可能降低接受口服双膦酸盐治疗的拔牙患者延迟恢复的风险:一项试验研究。
Clin Oral Investig. 2017 Sep;21(7):2165-2172. doi: 10.1007/s00784-016-2004-z. Epub 2016 Nov 11.
4
Usefulness of advanced-platelet rich fibrin (A-PRF) and injectable-platelet rich fibrin (i-PRF) in the management of a massive medication-related osteonecrosis of the jaw (MRONJ): A 5-years follow-up case report.富含血小板纤维蛋白(A-PRF)和可注射性富含血小板纤维蛋白(i-PRF)在治疗大剂量药物相关性颌骨坏死(MRONJ)中的应用:5 年随访病例报告。
Indian J Dent Res. 2020 Sep-Oct;31(5):813-818. doi: 10.4103/ijdr.IJDR_689_19.
5
Evaluation of different platelet-rich concentrates effects on early soft tissue healing and socket preservation after tooth extraction.评价不同富血小板浓缩物对拔牙后早期软组织愈合和牙槽窝保存的影响。
J Stomatol Oral Maxillofac Surg. 2020 Nov;121(5):539-544. doi: 10.1016/j.jormas.2019.09.005. Epub 2019 Sep 14.
6
Treatment of bisphosphonate-related osteonecrosis of the jaw using platelet-rich fibrin.使用富血小板纤维蛋白治疗双膦酸盐相关颌骨坏死。
Cranio. 2017 Sep;35(5):332-336. doi: 10.1080/08869634.2016.1203093. Epub 2016 Jun 30.
7
Scintigraphic evaluation of osteoblastic activity in extraction sockets treated with platelet-rich fibrin.富含血小板纤维蛋白治疗拔牙窝骨形成活性的骨闪烁显像评估
J Oral Maxillofac Surg. 2010 May;68(5):980-9. doi: 10.1016/j.joms.2009.09.092. Epub 2010 Feb 7.
8
The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw: A case series.富血小板纤维蛋白在药物相关性颌骨坏死中的应用:一项病例系列研究。
J Stomatol Oral Maxillofac Surg. 2020 Feb;121(1):84-89. doi: 10.1016/j.jormas.2019.02.011. Epub 2019 Feb 20.
9
Use of Leukocyte- and Platelet-Rich Fibrin to Prevent Osteonecrosis of the Jaws Associated with the Use of Bisphosphonate Therapy: A Case Series.使用富含白细胞和血小板的纤维蛋白预防与双膦酸盐治疗相关的颌骨坏死:病例系列
J Maxillofac Oral Surg. 2023 Dec;22(4):1159-1165. doi: 10.1007/s12663-023-02001-7. Epub 2023 Sep 7.
10
Prevention and management of drug-induced osteonecrosis of the jaws using platelet-rich fibrin: A clinical feasibility study.应用富血小板纤维蛋白预防和治疗药物性下颌骨坏死:一项临床可行性研究。
Clin Exp Dent Res. 2023 Oct;9(5):791-798. doi: 10.1002/cre2.775. Epub 2023 Aug 21.

引用本文的文献

1
Platelet-Rich Fibrin in MRONJ Management: A Prospective Comparative Study on Its Effectiveness in Prevention and Treatment.富含血小板纤维蛋白在颌骨放射性骨坏死管理中的应用:关于其预防和治疗效果的前瞻性对照研究
Medicina (Kaunas). 2025 Mar 28;61(4):625. doi: 10.3390/medicina61040625.
2
Use of Leukocyte- and Platelet-Rich Fibrin to Prevent Osteonecrosis of the Jaws Associated with the Use of Bisphosphonate Therapy: A Case Series.使用富含白细胞和血小板的纤维蛋白预防与双膦酸盐治疗相关的颌骨坏死:病例系列
J Maxillofac Oral Surg. 2023 Dec;22(4):1159-1165. doi: 10.1007/s12663-023-02001-7. Epub 2023 Sep 7.
3
Oral Microbiome, Oral Health and Systemic Health: A Multidirectional Link.

本文引用的文献

1
Platelet-Rich Fibrin and its Emerging Therapeutic Benefits for Musculoskeletal Injury Treatment.富含血小板纤维蛋白及其在肌肉骨骼损伤治疗中的新兴治疗益处。
Medicina (Kaunas). 2019 May 15;55(5):141. doi: 10.3390/medicina55050141.
2
The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw: A case series.富血小板纤维蛋白在药物相关性颌骨坏死中的应用:一项病例系列研究。
J Stomatol Oral Maxillofac Surg. 2020 Feb;121(1):84-89. doi: 10.1016/j.jormas.2019.02.011. Epub 2019 Feb 20.
3
Can platelet-rich fibrin improve healing after surgical treatment of medication-related osteonecrosis of the jaw? A pilot study.
口腔微生物群、口腔健康与全身健康:多向联系
Biomedicines. 2022 Jan 17;10(1):186. doi: 10.3390/biomedicines10010186.
4
Calcium Phosphate Ceramics Can Prevent Bisphosphonate-Related Osteonecrosis of the Jaw.磷酸钙陶瓷可预防双膦酸盐相关的颌骨坏死。
Materials (Basel). 2020 Apr 22;13(8):1955. doi: 10.3390/ma13081955.
富血小板纤维蛋白能否改善药物相关性颌骨骨坏死手术治疗后的愈合?一项初步研究。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Nov;126(5):390-403. doi: 10.1016/j.oooo.2018.06.007. Epub 2018 Jun 30.
4
Fifteen Years of Platelet Rich Fibrin in Dentistry and Oromaxillofacial Surgery: How High is the Level of Scientific Evidence?牙科和口腔颌面外科领域应用富血小板纤维蛋白的十五年:科学证据水平有多高?
J Oral Implantol. 2018 Dec;44(6):471-492. doi: 10.1563/aaid-joi-D-17-00179. Epub 2018 Jun 5.
5
Interventions for managing medication-related osteonecrosis of the jaw.颌骨药物相关性骨坏死的管理干预措施。
Cochrane Database Syst Rev. 2017 Oct 6;10(10):CD012432. doi: 10.1002/14651858.CD012432.pub2.
6
Platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: a clinical and histopathological evaluation.富血小板纤维蛋白在药物相关性颌骨坏死治疗中的应用:一项临床和组织病理学评估
J Biol Regul Homeost Agents. 2017 Jul-Sep;31(3):811-816.
7
The role of Leucocyte-rich and platelet-rich fibrin (L-PRF) in the treatment of the medication-related osteonecrosis of the jaws (MRONJ).富含白细胞和富血小板纤维蛋白(L-PRF)在颌骨药物相关性骨坏死(MRONJ)治疗中的作用。
J Clin Exp Dent. 2017 Aug 1;9(8):e1051-e1059. doi: 10.4317/jced.54154. eCollection 2017 Aug.
8
Use of platelet-rich fibrin in regenerative dentistry: a systematic review.富血小板纤维蛋白在再生牙科中的应用:系统评价。
Clin Oral Investig. 2017 Jul;21(6):1913-1927. doi: 10.1007/s00784-017-2133-z. Epub 2017 May 27.
9
Effectiveness of treatments for medication-related osteonecrosis of the jaw: A systematic review and meta-analysis.治疗药物相关性颌骨坏死的疗效:系统评价和荟萃分析。
J Am Dent Assoc. 2017 Aug;148(8):584-594.e2. doi: 10.1016/j.adaj.2017.04.002. Epub 2017 May 18.
10
A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?一项多中心回顾性研究,探讨了接受口服双膦酸盐治疗的拔牙后药物相关性颌骨坏死的相关风险因素:原发伤口闭合和药物暂停真的能预防 MRONJ 吗?
Osteoporos Int. 2017 Aug;28(8):2465-2473. doi: 10.1007/s00198-017-4063-7. Epub 2017 Apr 27.